Ultrasensitive antigen test for COVID-19

2020-1012-01
researcher's name
about researcher ITO, Etsuro Professor
affiliation
Faculty of Education and Integrated Arts and Sciences School of Education
keyword

background

● The PCR method is the definitive diagnosis for COVID-19. However, PCR is technically difficult to perform, time-consuming, and expensive, even though it is a highly sensitive measurement method.
● The global COVID-19 pandemic has increased the demand for accurate, easy-to-use, rapid, and cost-effective ‘antigen tests’ for clinical application. 

summary

● We propose a de novo antigen test for diagnosing COVID-19 using the combination of sandwich ELISA and thio-NAD cycling. Our test takes advantage of the spike (S1) proteins specific to the SARS-CoV-2 virus. 

predominance

● A trace amount of S1 protein at 2.3×10-18 moles/assay can be detected using an ultrasensitive ELISA combined with thio-NAD cycling. The thio-NAD cycling  is performed within tens of minutes. 
● The detection sensitivity approaches that of PCR-based assays.

application/development

● Our antigen test allows for ultrasensitive measurements of SARS-CoV-2, and has broad application for the diagnosis for COVID-19.
● Our present method is versatile, when we have specific antibodies against the target proteins.

material

same researcher's seeds

  • Development of new diagnosis using ultrasensitive ELISA
  • Activity change in the brain associated with pain relief
  • Sins of anticancer drugs
posted: 2020/10/27